Blood transfusion in cardiac surgery is a risk factor for increased hospital length of stay in adult patients
Carregando...
Citações na Scopus
56
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
SILVA, Carolina M. P. D. C.
VINCENT, Jean-Louis
Citação
JOURNAL OF CARDIOTHORACIC SURGERY, v.8, article ID 54, 7p, 2013
Resumo
Background: Allogeneic red blood cell (RBC) transfusion has been proposed as a negative indicator of quality in cardiac surgery. Hospital length of stay (LOS) may be a surrogate of poor outcome in transfused patients. Methods: Data from 502 patients included in Transfusion Requirements After Cardiac Surgery (TRACS) study were analyzed to assess the relationship between RBC transfusion and hospital LOS in patients undergoing cardiac surgery and enrolled in the TRACS study. Results: According to the status of RBC transfusion, patients were categorized into the following three groups: 1) 199 patients (40%) who did not receive RBC, 2) 241 patients (48%) who received 3 RBC units or fewer (low transfusion requirement group), and 3) 62 patients (12%) who received more than 3 RBC units (high transfusion requirement group). In a multivariable Cox proportional hazards model, the following factors were predictive of a prolonged hospital length of stay: age higher than 65 years, EuroSCORE, valvular surgery, combined procedure, LVEF lower than 40% and RBC transfusion of >3 units. Conclusion: RBC transfusion is an independent risk factor for increased LOS in patients undergoing cardiac surgery. This finding highlights the adequacy of a restrictive transfusion therapy in patients undergoing cardiac surgery.
Palavras-chave
Transfusion, Cardiac surgery, Length of stay
Referências
- Bennett-Guerrero E, 2010, JAMA-J AM MED ASSOC, V304, P1568, DOI 10.1001/jama.2010.1406
- De Cocker J, 2011, EUR J CARDIO-THORAC, V39, P60, DOI 10.1016/j.ejcts.2010.04.015
- Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078
- Gauvin F, 2008, TRANSFUSION, V48, P801, DOI 10.1111/j.1537-2995.2007.01614.x
- Gauvin F, 2005, EUR J CARDIO-THORAC, V27, P128
- Hajjar LA, JAMA, V304, P1559
- Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601
- Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8
- Kuduvalli M, 2005, EUR J CARDIO-THORAC, V27, P592, DOI 10.1016/j.ejcts.2005.01.030
- Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677
- Mohnle P, 2011, INTENS CARE MED, V37, P97, DOI 10.1007/s00134-010-2017-z
- Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977
- Pagowska-Klimek I, 2011, EUR J CARDIO-THORAC, V40, P179, DOI 10.1016/j.ejcts.2010.11.038
- Surgenor SD, 2009, ANESTH ANALG, V108, P1741, DOI 10.1213/ane.0b013e3181a2a696
- VAMVAKAS EC, 1995, TRANSFUSION, V35, P760, DOI 10.1046/j.1537-2995.1995.35996029162.x